Intercure (INCR) director David Salton reports option positions in Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Intercure Ltd. director David Salton filed an initial Form 3 detailing his existing option holdings, rather than new trades. He reports share options over 4,046 ordinary shares with a converted exercise price of $8.22 per share, expiring on January 9, 2030; these options were granted in 2020 and became fully vested on January 9, 2023. He also reports share options over 15,000 ordinary shares with a converted exercise price of $3.10 per share, expiring on September 5, 2028, which were granted on September 5, 2024 and vest quarterly over four years.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Salton David
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share options (right to buy) | -- | -- | -- |
| holding | Share options (right to buy) | -- | -- | -- |
Holdings After Transaction:
Share options (right to buy) — 4,046 shares (Direct)
Footnotes (1)
- The options were granted on January 9, 2020, and the current exercise price is NIS 25.146 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $8.22 per share. The options became fully vested as of January 9, 2023. The options were granted on September 5, 2024 and the current exercise price is NIS 9.50 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $3.10 per share. The options vest on a quarterly basis over four years from the date of grant.
Key Figures
Underlying shares (2020 grant): 4,046 shares
Exercise price (2020 options): $8.22 per share
Expiration (2020 options): January 9, 2030
+5 more
8 metrics
Underlying shares (2020 grant)
4,046 shares
Share options over ordinary shares from January 9, 2020 grant
Exercise price (2020 options)
$8.22 per share
Converted from NIS 25.146 using 3.06 NIS/USD as of April 14, 2026
Expiration (2020 options)
January 9, 2030
Expiry date for options over 4,046 ordinary shares
Underlying shares (2024 grant)
15,000 shares
Share options over ordinary shares from September 5, 2024 grant
Exercise price (2024 options)
$3.10 per share
Converted from NIS 9.50 using 3.06 NIS/USD as of April 14, 2026
Expiration (2024 options)
September 5, 2028
Expiry date for options over 15,000 ordinary shares
Vesting status (2020 options)
Fully vested
Became fully vested on January 9, 2023
Vesting schedule (2024 options)
Quarterly over four years
From September 5, 2024 grant date
Key Terms
Share options (right to buy), exercise price, underlying security, vested, +1 more
5 terms
exercise price financial
"the current exercise price is NIS 25.146 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
underlying security financial
"underlying_security_title: "Ordinary Shares""
vested financial
"The options became fully vested as of January 9, 2023"
Form 3 regulatory
"For purposes of this Form 3, the exercise price has been converted"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
FAQ
What does the Intercure Ltd. (INCR) Form 3 filing by David Salton show?
The Form 3 shows director David Salton’s existing option holdings in Intercure Ltd., including options over 4,046 shares at $8.22 and 15,000 shares at $3.10. It reports positions only, without indicating recent purchases or sales.
What are the exercise prices of David Salton’s Intercure Ltd. (INCR) options?
The filing states converted exercise prices of $8.22 per share for options over 4,046 shares and $3.10 per share for options over 15,000 shares. These amounts are translated from NIS using a 3.06 NIS to $1.00 exchange rate as of April 14, 2026.
When do David Salton’s Intercure Ltd. (INCR) options vest and expire?
Options over 4,046 shares fully vested on January 9, 2023 and expire on January 9, 2030. Options over 15,000 shares were granted September 5, 2024, vest quarterly over four years, and expire on September 5, 2028, according to the disclosure.